Risk‐reducing salpingo‐oophorectomy (RRSO) vs no RRSO
HGSC mortality: BRCA1 or BRCA2
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes HGSC mortality: BRCA1 or BRCA2 compared with no RRSO (very low certainty).
1 finding from 1 review
- Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations 2018 · Cochrane Headline outcomes onlyHR 0.06 [0.02, 0.17]3 studies · 2534 participantsVery low